Biotechnology & Life Sciences Global On demand · 24-48h

Global Beef Genomic Testing Service Market Strategic Research Report

Global Beef Genomic Testing Service Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Beef Genomic Testing Service Market
$6.85B2025
5.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Genotic Chip Array, Whole Genome Resequencing, Targeted Sequencing Genotyping

By Application: Breeding Farm, Fattening Farm, Processing Plant, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Illumina, Inc. (NASDAQ: ILMN, California USA), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Genus plc (LSE: GNS, Basingstoke UK), Zoetis Inc. (NYSE: ZTS, New Jersey USA), Neogen Corporation (NASDAQ: NEOG, Michigan USA), Delta Genomics (Unlisted, Alberta Canada), VHL Genetics (Unlisted, Wageningen Netherlands), CD Genomics (Unlisted, New York USA), Novogene Co., Ltd. (SSE: 688315, Beijing China), BGI Group (Unlisted, Shenzhen China), Higentec Co., Ltd. (Unlisted, Changsha China), Beijing Compass Biotechnology Co., Ltd. (Unlisted, Beijing China), MolBreeding Biotechnology Co., Ltd. (Unlisted, Hebei China)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 112 pages
Market size 2025
$6.85B
Billion USD
Forecast CAGR
5.2%
2025-2032
Forecast 2032
$9.8B
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Beef Genomic Testing Service market size is predicted to grow from US$ 6,848 million in 2025 to US$ 9,711 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

Beef genomic testing service is a professional service that use gene sequencing and microarray technology to scan and analyze the entire genome or key gene loci of individual beef cattle. Its core function is to transform invisible genetic potential into quantifiable breeding data, solving the fundamental problems of traditional beef cattle breeding, such as long phenotypic selection cycles, low efficiency, and the inability to accurately predict breeding performance, disease risk, and offspring genetic value in the early stages. This represents a leap from "experience-based breeding" to "precision breeding." Upstream are technology, equipment, and data providers, including gene sequencer and microarray manufacturers, bioinformatics software companies, and global beef cattle genotype and phenotypic databases. Downstream, it directly serves core participants in the beef cattle industry, primarily including: 1. Breeding farms (for selecting top-performing bulls and core cows); 2. Commercial fattening farms (for screening high-performance feeder cattle and optimizing fattening herds); 3. Slaughtering and processing enterprises and brand owners (for tracing the genetic origin of meat, ensuring consistent meat quality, and brand marketing). In 2025, the average price of beef genomic testing service was approximately US$120 per head, with a gross profit margin of approximately 45%.

Global key Beef Genomic Testing Service players cover Illumina, Inc. (NASDAQ: ILMN, California USA), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Genus plc (LSE: GNS, Basingstoke UK), Zoetis Inc. (NYSE: ZTS, New Jersey USA), Neogen Corporation (NASDAQ: NEOG, Michigan USA), etc.

This report presents a comprehensive overview of the global Beef Genomic Testing Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Genotic Chip Array
  • Whole Genome Resequencing
  • Targeted Sequencing Genotyping

Segment by Detection Purpose

  • Production Trait Evaluation
  • Reproduction and Health Trait Evaluation
  • Breed Purity and Composition Analysis

Segment by Application

  • Breeding Farm
  • Fattening Farm
  • Processing Plant
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Beef Genomic Testing Service market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Breeding Farm, Fattening Farm, Processing Plant evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Beef Genomic Testing Service Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$6.85B
2025
Forecast
$9.8B
2032
CAGR
5.2%
2025–2032
区域
5
global
Key companies
IlluminaInc. (NASDAQ: ILMNCalifornia USA)Thermo Fisher Scientific Inc. (NYSE: TMOMassachusetts USA)Genus plc (LSE: GNSBasingstoke UK)Zoetis Inc. (NYSE: ZTS
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Genotic Chip ArrayWhole Genome ResequencingTargeted Sequencing Genotyping
By Application
Breeding FarmFattening FarmProcessing PlantOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Genotic Chip Array
  • 3.1.3 Whole Genome Resequencing
  • 3.1.4 Targeted Sequencing Genotyping
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Breeding Farm
  • 4.1.3 Fattening Farm
  • 4.1.4 Processing Plant
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Illumina, Inc. (NASDAQ: ILMN, California USA)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Genus plc (LSE: GNS, Basingstoke UK)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Zoetis Inc. (NYSE: ZTS, New Jersey USA)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Neogen Corporation (NASDAQ: NEOG, Michigan USA)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Delta Genomics (Unlisted, Alberta Canada)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 VHL Genetics (Unlisted, Wageningen Netherlands)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 CD Genomics (Unlisted, New York USA)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Novogene Co., Ltd. (SSE: 688315, Beijing China)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 BGI Group (Unlisted, Shenzhen China)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Higentec Co.,Ltd. (Unlisted, Changsha China)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Beijing Compass Biotechnology Co., Ltd. (Unlisted, Beijing China)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 MolBreeding Biotechnology Co., Ltd. (Unlisted, Hebei China)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Beef Genomic Testing Service market?
The global Beef Genomic Testing Service market is estimated at US$ 6.85 billion in 2025 (base year) and is projected to reach US$ 9.71 billion by 2032.
How fast is the Beef Genomic Testing Service market expected to grow?
The market is expected to grow at a CAGR of 5.2% from 2026 to 2032, expanding from US$ 6.85 billion in 2025 to US$ 9.71 billion in 2032, roughly 1.4 times its base-year value.
What does the Beef Genomic Testing Service market cover?
Beef genomic testing service is a professional service that use gene sequencing and microarray technology to scan and analyze the entire genome or key gene loci of individual beef cattle. Its core function is to transform invisible genetic potential into quantifiable breeding data, solving the fundamental problems of traditional beef cattle breeding, such as long phenotypic selection cycles, low efficiency, and the inability to accurately predict breeding performance, disease risk, and offspring genetic value in the early stages.
How is the Beef Genomic Testing Service market segmented by type?
By type, the market is segmented into Genotic Chip Array, Whole Genome Resequencing and Targeted Sequencing Genotyping.
What are the key applications of Beef Genomic Testing Service?
Key applications covered include Breeding Farm, Fattening Farm, Processing Plant and Other.
Which companies are profiled in the Beef Genomic Testing Service market report?
Key players profiled include Illumina, Inc. (NASDAQ: ILMN, California USA), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Genus plc (LSE: GNS, Basingstoke UK), Zoetis Inc. (NYSE: ZTS, New Jersey USA), Neogen Corporation (NASDAQ: NEOG, Michigan USA), Delta Genomics (Unlisted, Alberta Canada), VHL Genetics (Unlisted, Wageningen Netherlands) and CD Genomics (Unlisted, New York USA), among 13 companies covered in total.
What geographies does the Beef Genomic Testing Service market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Beef Genomic Testing Service market report?
The report is intended for manufacturers and solution providers, distributors and end users in Breeding Farm, Fattening Farm and Processing Plant, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Beef Genomic Testing Service market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.